-
Where the Opioids Go
The idea is that suffering isn’t always preventable, but a few cents’ worth of morphine can make an enormous difference. Some 45 percent of the 56.2 million people who died in 2015 experienced serious suffering, the authors found. That included 2.5 million children. More than 80 percent of the people were from developing regions, and the vast majority had no access to palliative care and pain relief.
- Categories
- Health Care
-
As Cancer Tears Through Africa, Drug Makers Draw Up a Battle Plan
Cancer now kills about 450,000 Africans a year. By 2030, it will kill almost 1 million annually, the World Health Organization predicts. The most common African cancers are the most treatable, including breast, cervical and prostate tumors. But here they are often lethal. In the United States, 90 percent of women with breast cancer survive five years. In Uganda, only 46 percent do; in Gambia, a mere 12 percent do.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Glasses for the Masses: Because It’s Easier to Navigate a Path out of Poverty When You Can See
On this World Sight Day, VisionSpring President Ella R. Gudwin writes that though eyeglasses are a cost-effective poverty reduction tool, 2.5 billion people do not have the eyeglasses they need to earn and learn. Gudwin announces a new partnership with Target and Williams-Sonoma Inc. that aims to improve workers' vision on a grand scale to bridge the visual divide.
- Categories
- Health Care
-
Doctors on the cusp of launching the first male contraceptive
Despite a survey from 2000 that found 83 percent of men from various countries would take a contraceptive, pharmaceutical companies seem reluctant to pursue a male contraceptive beyond what is already on the market. Without backing from big pharma, some small companies are receiving grants from large public health organizations, such as the Bill and Melinda Gates Foundation, which in 2016 donated $600,000 for the development of male contraceptives.
- Categories
- Health Care
-
India grants Pfizer patent on pneumonia vaccine in blow to aid group
The decision by India's patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India until 2026. It's a big victory for the U.S. drugmaker in a market that has the world's largest number of pneumonia cases, a lung disease that kills nearly a million children a year globally.
- Categories
- Health Care
- Region
- South Asia
-
India to Block $1.3 Billion Chinese Pharmaceutical Takeover, Sources Say
Tensions between India and China -- the South Asian nation’s biggest trading partner -- have escalated amid a renewed spat over territory in a remote area of the Himalayas, one of the most serious flareups since a border war in 1962.
- Categories
- Health Care
- Region
- South Asia
- Tags
- China, India, pharmaceutical industry, trade
-
Price fixation of essential drugs hits profitability: Novartis
The government's push for prescribing the drugs by generic names could pose further challenges, Novartis India said in the latest annual report for 2016-17.
- Categories
- Health Care
- Region
- South Asia
-
Q&A: Rajeev Venkayya on why vaccines are a worthy investment
Venkayya has seen vaccines from every angle. Before launching Takeda’s global vaccine business five years ago, he served as senior director for biodefense at the White House and director of global health delivery at the Bill & Melinda Gates Foundation. The success of vaccines going forward, he says, requires public and policy support for investments “to make sure that we're driving strong immunization coverage everywhere but also investing in new vaccines for the diseases that should be vaccine preventable,” he said.
- Categories
- Health Care
Parent Organization
